Literature DB >> 2164902

Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis.

D S Kumararatne1, A S Pithie, P Drysdale, J S Gaston, R Kiessling, P B Iles, C J Ellis, J Innes, R Wise.   

Abstract

The cytolytic capacity of mycobacterial antigen-stimulated peripheral blood mononuclear cells, from healthy Mantoux-positive volunteers and from patients with tuberculosis was investigated. Polyclonal T cell lines induced by 7 days of stimulation in vitro with PPD or a sonicate of Mycobacterium tuberculosis lysed both autologous macrophages and Epstein-Barr virus (EBV) transformed B cell lines which had been pulsed with mycobacterial antigens, to a greater extent than unpulsed target cells or target cells pulsed with an irrelevant antigen (streptokinase/streptodornase). The killing of mycobacterial antigen-pulsed macrophages and EBV-transformed B cell line targets was inhibited by monoclonal antibodies to MHC class II antigens but not by antibodies directed against MHC class I antigens. PPD-pulsed EBV-transformed lymphoblastoid cell lines (LCL) competitively inhibited the killing of mycobacterial antigen-pulsed macrophages, whereas natural killer (NK) sensitive K562 cells (with or without antigen pulsing) did not inhibit mycobacterial antigen-dependent cytolysis of macrophages. Patients with tuberculosis showed a spectrum of mycobacterial antigen-induced cytolytic capacity. Those with extensive tissue necrosis (e.g. cavitatory pulmonary tuberculosis or caseous, extrathoracic tuberculosis) had high levels while patients with disseminated (miliary) tuberculosis or disease refractory to treatment showed little evidence of mycobacterial antigen induced cytotoxicity. The ability of mycobacterial antigen-stimulated lymphoblasts to kill specific antigen-pulsed autologous macrophages was not significantly different between healthy donors and patients with tuberculosis. However, the 'mycobacterial antigen-specific' component of this cytolysis was significantly deficient (P less than 0.01) in patients. We conclude that mycobacterial antigen-specific cytotoxic T cell responses may play a significant part in the immune response to mycobacterial infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164902      PMCID: PMC1535202          DOI: 10.1111/j.1365-2249.1990.tb03287.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  T cell-mediated cytotoxicity induced by Listeria monocytogenes. II. Specificity of cytolytic effector cells.

Authors:  M C Woan; D D McGregor; U Forsum
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

Review 2.  Bacteriologic basis of short-course chemotherapy for tuberculosis.

Authors:  J Grosset
Journal:  Clin Chest Med       Date:  1980-05       Impact factor: 2.878

3.  Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin.

Authors:  I M Orme; F M Collins
Journal:  Cell Immunol       Date:  1984-03       Impact factor: 4.868

4.  T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A.

Authors:  A B Rickinson; M Rowe; I J Hart; Q Y Yao; L E Henderson; H Rabin; M A Epstein
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

5.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

6.  The use of murine monoclonal antibodies without purification of antigen in the serodiagnosis of tuberculosis.

Authors:  J Hewitt; A R Coates; D A Mitchison; J Ivanyi
Journal:  J Immunol Methods       Date:  1982-12-17       Impact factor: 2.303

7.  Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice.

Authors:  L Nencioni; L Villa; D Boraschi; B Berti; A Tagliabue
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

8.  Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida.

Authors:  A E Pitchenik; C Cole; B W Russell; M A Fischl; T J Spira; D E Snider
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

9.  Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.

Authors:  L E Wallace; D J Moss; A B Rickinson; A J McMichael; M A Epstein
Journal:  Eur J Immunol       Date:  1981-09       Impact factor: 5.532

10.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  23 in total

1.  Cellular interactions in bovine tuberculosis: release of active mycobacteria from infected macrophages by antigen-stimulated T cells.

Authors:  E Liebana; A Aranaz; F E Aldwell; J McNair; S D Neill; A J Smyth; J M Pollock
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Unusual spinal tuberculosis after adequate chemotherapy for lymph node tuberculosis in an immunocompetent man.

Authors:  S P O'Hickey; A Pithie; C Skinner
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

3.  Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65.

Authors:  C L Silva; M F Silva; R C Pietro; D B Lowrie
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 4.  Is macrophage death on the field of battle essential to victory, or a tactical weakness in immunity against tuberculosis?

Authors:  D B Lowrie
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

5.  Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro.

Authors:  J Turner; H M Dockrell
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

6.  Lack of cytotoxic activity against Mycobacterium leprae 65-kD heat shock protein (hsp) in multibacillary leprosy patients.

Authors:  S de la Barrera; S Fink; M Finiasz; F Minnucci; R Valdez; L M Baliña; M C Sasiain
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

7.  Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis.

Authors:  Margot A Skinner; Natalie Parlane; Allison McCarthy; Bryce M Buddle
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.

Authors:  M C Sasiain; S de la Barrera; S Fink; M Finiasz; M Alemán; M H Fariña; G Pizzariello; R Valdez
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

9.  Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis.

Authors:  L T Ratcliffe; P T Lukey; C R MacKenzie; S R Ress
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis.

Authors:  S S De La Barrera; M Finiasz; A Frias; M Alemán; P Barrionuevo; S Fink; M C Franco; E Abbate; M del C Sasiain
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.